SEC Filing Summary: National Health Investors Inc (NHI)
Business Context and Reporting Period
This Form 8-K, filed on November 5, 2024, serves as a Regulation FD disclosure for National Health Investors Inc. The filing provides supplemental information for the quarter ended September 30, 2024. The company is a Maryland corporation listed on the New York Stock Exchange under the symbol NHI.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the referenced "Supplemental Information" document (Exhibit 99.1) hosted on the company's website, which is not included in the provided text.
Material Changes
The filing does not detail specific material changes versus the prior comparable period within the text body. It solely references the availability of supplemental data for the quarter ended September 30, 2024.
Guidance, Outlook, and Risks
Management commentary, forward-looking guidance, specific risks, contingencies, or unusual items are not described in the filing text. The document acts as a notice that such information is available in the attached Exhibit 99.1.
Investor Verification Checklist
- Verify the specific financial figures for the quarter ended September 30, 2024, by reviewing Exhibit 99.1 on the company website (www.nhireit.com).
- Confirm the details of the supplemental information referenced in Item 7.01 to understand the context of the disclosure.
- Check for any subsequent updates or press releases that may elaborate on the supplemental data provided in this filing.